<DOC>
	<DOCNO>NCT01262261</DOCNO>
	<brief_summary>Probuphine ( buprenorphine implant ) investigational implant place skin contain buprenorphine ( BPN ) . BPN approve treatment opioid dependence . This 6-month , open-label , re-treatment study confirm safety efficacy Probuphine patient previously complete 6-month PRO-806 study either Probuphine , placebo sublingual buprenorphine .</brief_summary>
	<brief_title>Re-Treatment Study Probuphine Opioid Addiction</brief_title>
	<detailed_description />
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Subject voluntarily provide write informed consent prior conduct studyrelated procedure Completion 24 week treatment PRO806 Subject deem appropriate entry extension study investigator Females childbearing potential must willing use reliable mean contraception entire study . An aspartate aminotransferase ( AST ) level ≥ 3 X upper limit normal , alanine aminotransferase ( ALT ) level ≥ 3 X upper limit normal , total bilirubin ≥ 1.5 X upper limit normal , creatinine ≥ 1.5 X upper limit normal screen laboratory assessment A current diagnosis chronic pain require opioids treatment A pregnant lactate female Current use agent metabolize Cytochrome P450 3A4 ( CYP 3A4 ) azole antifungal ( e.g. , ketoconazole ) , macrolide antibiotic ( e.g. , erythromycin ) , protease inhibitor ( e.g. , ritonavir , indinavir , saquinavir ) A history coagulopathy within past 90 day , and/or current anticoagulant therapy warfarin A significant medical psychiatric symptom , cognitive impairment , factor opinion Investigator would preclude compliance protocol , subject safety , adequate cooperation study , obtain informed consent Any current medical condition severe respiratory insufficiency may prevent subject safely participate study , pending legal action could prohibit participation compliance study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>opioid addiction</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>implant</keyword>
	<keyword>methadone</keyword>
	<keyword>heroin</keyword>
	<keyword>suboxone</keyword>
	<keyword>opioid pain medication</keyword>
	<keyword>opioid withdrawal</keyword>
</DOC>